ATE550664T1 - Multiplex-screening auf lysosomale speicherkrankheiten (lsds) - Google Patents

Multiplex-screening auf lysosomale speicherkrankheiten (lsds)

Info

Publication number
ATE550664T1
ATE550664T1 AT04724491T AT04724491T ATE550664T1 AT E550664 T1 ATE550664 T1 AT E550664T1 AT 04724491 T AT04724491 T AT 04724491T AT 04724491 T AT04724491 T AT 04724491T AT E550664 T1 ATE550664 T1 AT E550664T1
Authority
AT
Austria
Prior art keywords
lysosomal
lsd
storage diseases
lysosomal storage
lsds
Prior art date
Application number
AT04724491T
Other languages
English (en)
Inventor
Peter Meikle
John Hopwood
Douglas Brooks
Caroline Dean
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003901451A external-priority patent/AU2003901451A0/en
Priority claimed from AU2003904174A external-priority patent/AU2003904174A0/en
Priority claimed from AU2003904720A external-priority patent/AU2003904720A0/en
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE550664T1 publication Critical patent/ATE550664T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT04724491T 2003-03-31 2004-03-31 Multiplex-screening auf lysosomale speicherkrankheiten (lsds) ATE550664T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2003901451A AU2003901451A0 (en) 2003-03-31 2003-03-31 An improved method of screening for lysosomal storage disorders (LSD)
AU2003904174A AU2003904174A0 (en) 2003-08-08 2003-08-08 Multiplex screening for lysosomal storagge disorders (lsds)
AU2003904720A AU2003904720A0 (en) 2003-09-01 Multiplex screening for lysosomal storage disorders (LSDs)
PCT/AU2004/000403 WO2004088322A1 (en) 2003-03-31 2004-03-31 MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs)

Publications (1)

Publication Number Publication Date
ATE550664T1 true ATE550664T1 (de) 2012-04-15

Family

ID=33135374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04724491T ATE550664T1 (de) 2003-03-31 2004-03-31 Multiplex-screening auf lysosomale speicherkrankheiten (lsds)

Country Status (8)

Country Link
US (2) US8173443B2 (de)
EP (1) EP1616193B1 (de)
JP (1) JP4833831B2 (de)
AT (1) ATE550664T1 (de)
CA (1) CA2524272A1 (de)
NO (1) NO20055025L (de)
NZ (1) NZ543309A (de)
WO (1) WO2004088322A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
US8765690B2 (en) * 2007-04-05 2014-07-01 Threshold Pharmaceuticals, Inc. Treatment of cancer with glufosfamide in patients not receiving insulin therapy
US8497122B2 (en) 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
EP2277049A4 (de) * 2008-05-09 2012-05-30 Univ Duke Autoantikörper für den nachweis und die behandlung von krebs
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
JP6168497B2 (ja) * 2012-03-30 2017-07-26 国立大学法人 岡山大学 抗体検出用試薬の製造方法、及びその用途
TR201906195T4 (tr) * 2013-05-14 2019-05-21 Centogene Ag Niemann pıck hastalığının teşhisi için metot.
US10196668B2 (en) 2013-09-05 2019-02-05 University Of Washington Through Its Center For Commercialization Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII
CN106018303A (zh) * 2016-07-12 2016-10-12 安徽伊普诺康生物技术股份有限公司 一种测定α-L-岩藻糖苷酶的试剂盒
EP3861018A4 (de) 2018-10-05 2022-10-26 Seattle Children's Hospital d/b/a Seattle Children's Research Institute Neugeborenenscreening für primäre immundefizienzen cystinose und morbus wilson
JP7689746B2 (ja) * 2019-12-17 2025-06-09 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 酵素酸性αグルコシダーゼ（ＧＡＡ）の結合タンパク質及びその使用
WO2021202807A1 (en) * 2020-03-31 2021-10-07 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Proteomic screening for lysosomal storage diseases
WO2021203031A2 (en) 2020-04-02 2021-10-07 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Antibodies that specifically bind peptides associated with the primary immunodeficiencies: wiskott-aldrich syndrome and x-linked agammaglobulinemia
CN113049715B (zh) * 2021-03-31 2023-03-17 宝枫生物科技（北京）有限公司 用于诊断脑白质病变的生物标志物及其应用
CA3261746A1 (en) 2022-07-19 2024-01-25 Genzyme Corporation LYSOSOMAL STORAGE DISEASE BIOMARKERS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010340A1 (en) * 1992-10-30 1994-05-11 Mt. Sinai Hospital Corporation Method for measuring glycosyltransferase activity
ATE496288T1 (de) * 1995-10-11 2011-02-15 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
AUPN991796A0 (en) 1996-05-17 1996-06-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
AU714818B2 (en) * 1996-05-17 2000-01-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
EP1163527B1 (de) 1999-03-17 2009-03-04 Women's And Children's Hospital Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern
US7465540B2 (en) * 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
AUPS293002A0 (en) 2002-06-14 2002-07-04 Women's And Children's Hospital Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders

Also Published As

Publication number Publication date
US20120184050A1 (en) 2012-07-19
US8735173B2 (en) 2014-05-27
CA2524272A1 (en) 2004-10-14
WO2004088322A1 (en) 2004-10-14
JP4833831B2 (ja) 2011-12-07
EP1616193B1 (de) 2012-03-21
EP1616193A4 (de) 2006-07-05
EP1616193A1 (de) 2006-01-18
US8173443B2 (en) 2012-05-08
NZ543309A (en) 2008-12-24
NO20055025L (no) 2006-01-02
NO20055025D0 (no) 2005-10-28
JP2006523300A (ja) 2006-10-12
US20070072243A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
EP1616193A4 (de) Multiplex-screening auf lysosomale speicherkrankheiten (lsds)
BRPI0208597B8 (pt) meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE337413T1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
ATE316147T1 (de) Enzymsensor
WO2006063042A3 (en) Selecting patients for therapy with a her inhibitor
ATE462016T1 (de) System zum nachweis von tierprodukten
WO2001027624A3 (en) Compositions and methods for detecting protein modification and enzymatic activity
WO2008115518A3 (en) Biomarkers of sirtuin activity and methods of use thereof
ATE424560T1 (de) Marker für neuromyelitis optica
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
WO2006055739A3 (en) Stationary phase antibody arrays for trace protein analysis
TW200504223A (en) Methods of assessment of drug metabolizing enzymes
WO2003087761A3 (en) Molecular profiling of disease and therapeutic response using phospho-specific antibodies
ATE553386T1 (de) Bluttypisierung
WO2026024964A3 (en) Methods and systems for characterizing proteoform markers of parkinson's disease
WO2011072007A3 (en) Methods and compositions for detection and identification of organophosphorus nerve agents, pesticides and other toxins
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
WO2004087070A3 (en) METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
ATE424562T1 (de) Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
EP1529849A8 (de) Zuverlässiges Verfahren zur Beurteillung und zum Berichten der von einem oder mehreren in einem Matrix oder der Umwelt sich befindenden Mikroorganismen bedingten Krankheits-, Kontaminations- oder Verlustrisiken
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
EP1575997A4 (de) Phosphospezifische pak-antikörper unddiagnostische kits
NO20042089L (no) Fremgangsmate for a screene legemiddel som virker pa cellevegg